Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings, Inc. develops medical technology for spine surgery, with a business centered on procedural spine solutions, surgical instrumentation, imaging, navigation and informatics. Company updates commonly address surgical revenue trends, EOS revenue, surgeon adoption, product launches such as Valence and EOS Insight, and the continued development of its InformatiX platform through subsidiaries including Alphatec Spine, EOS imaging and SafeOp Surgical.
Recurring developments also include financing actions, credit-facility activity, strategic partnerships tied to spinal fusion and regenerative technology, profitability metrics and annual outlook updates. Governance items, including board composition changes, appear alongside operating results and capital-structure announcements.
Alphatec Holdings Inc. (Nasdaq: ATEC) announced an Investor Day scheduled for May 25, 2022, from 8:00 a.m. PT to 12:00 p.m. PT at its headquarters in Carlsbad, CA. This event aims to showcase ATEC's innovative strategies in spine surgery, address market opportunities, and outline its long-term financial outlook. A live webcast will begin at 8:15 a.m. PT, allowing registered participants to submit questions. A replay will be available post-event. For registration and further details, visit the Investor Relations Section of ATEC's website.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced that Pat Miles, Chairman and CEO, and Todd Koning, CFO, will present at the 21st Annual Needham Virtual Healthcare Conference on April 11, 2022, at 11:45 am ET. A webcast and an archived recording of the presentation will be available in the Investor Relations Section of the company’s website. Alphatec is focused on innovative spine surgery solutions and aims to be the Standard Bearer in Spine through its Organic Innovation Machine™ and the AlphaInformatiX Platform.
Alphatec Holdings, Inc. (ATEC) reported a 68% revenue growth for 2021, with total revenue reaching $243.2 million and Q4 revenue at $74 million. Organic growth in the U.S. was 50%, with a 3-year CAGR of 36%. The GAAP gross margin stood at 64.9%, while operating expenses totaled $285.8 million. ATEC expects 2022 revenue to approximate $305 million, marking a 25% increase. EOS imaging-related revenue contributed $12.8 million. The company trained over 400 surgeons in 2021, enhancing its market presence.
Alphatec Holdings, Inc. (NASDAQ: ATEC) has announced its participation in three upcoming investor conferences. Pat Miles, CEO, and Todd Koning, CFO, will present at the following events:
- The 11th Annual SVB Leerink Global Healthcare Conference: February 17, 2022, at 4:20 pm ET
- The 42nd Annual Cowen Healthcare Conference: March 7, 2022, at 2:50 pm ET
- The 17th Annual Canaccord Genuity Musculoskeletal Conference: March 22, 2022, at 1:00 pm CT
Webcasts will be available on the company's Investor Relations Section.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will announce its fourth quarter and full year 2021 financial results on March 1, 2022, after market close. A live webcast is scheduled for 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the webcast through the Investor Relations Section of ATEC’s website. A replay will be available for twelve months post-event.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced impressive preliminary revenue results for Q4 and full-year 2021, reflecting a 41-42% U.S. organic revenue growth in Q4 and an annual growth of 50-51%. The total revenue for 2021 is expected between $242.5M to $243.3M. For 2022, ATEC anticipates a 26% growth, targeting approximately $305M in total revenue. Highlights include strong uptake of the PTP™ approach and innovative offerings, driving clinical distinction and market expansion.
Alphatec Holdings, Inc. (Nasdaq: ATEC) will present at the 24th Annual Virtual Needham Growth Conference on January 14, 2022, at 1:15 PM ET. The presentation will be made by Pat Miles, Chairman and CEO, and Todd Koning, CFO. A live webcast will be available on the Company’s website, with a replay accessible for 90 days thereafter. ATEC focuses on innovative spine surgery solutions through its subsidiaries, seeking to revolutionize the approach to spine surgery.
Alphatec Holdings, Inc. (Nasdaq: ATEC) reported a significant total revenue growth of 53% for Q3 2021, with organic growth at 29%. The company's total revenue reached $62.9 million, and EOS imaging contributed over $11 million. Operating expenses were $74.7 million leading to a GAAP operating loss of $35.1 million. Looking ahead, ATEC anticipates total revenue for 2021 to be around $235 million, marking approximately 62% growth year-over-year. The adoption of the PTP Technique and enhanced product offerings are driving these results.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced today its participation in several upcoming investor conferences. Pat Miles, Chairman and CEO, and Todd Koning, CFO, will represent the company at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021, the Stifel Healthcare Conference on November 16, 2021, and the Piper Sandler Conference from November 22 to December 2, 2021. They will also partake in the Stifel Medtech Madness Annual West Coast Bus Tour on December 13, 2021. Webcast replays will be available for 90 days post-conference.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced it will release its third quarter 2021 financial results on November 4, 2021, after market close. A live webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET. Interested participants can access the webcast via ATEC's Investor Relations website. The results and insights from the call will be available for replay until November 11, 2021.